FLOCOUMAFEN -- A NEW ANTICOAGULANT RODENTICIDE by Lund, M.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Proceedings of the Thirteenth Vertebrate Pest 
Conference (1988) 
Vertebrate Pest Conference Proceedings 
collection 
February 1988 
FLOCOUMAFEN -- A NEW ANTICOAGULANT RODENTICIDE 
M. Lund 
Danish Pest Infestation Laboratory, Lyngby, Denmark 
Follow this and additional works at: https://digitalcommons.unl.edu/vpcthirteen 
 Part of the Environmental Health and Protection Commons 
Lund, M., "FLOCOUMAFEN -- A NEW ANTICOAGULANT RODENTICIDE " (1988). Proceedings of the 
Thirteenth Vertebrate Pest Conference (1988). 12. 
https://digitalcommons.unl.edu/vpcthirteen/12 
This Article is brought to you for free and open access by the Vertebrate Pest Conference Proceedings collection at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Proceedings of the 
Thirteenth Vertebrate Pest Conference (1988) by an authorized administrator of DigitalCommons@University of 
Nebraska - Lincoln. 
FLOCOUMAFEN -- A NEW ANTICOAGULANT RODENTICIDE 
M. LUND, Danish Pest Infestation Laboratory, Skovbrynet 14, 2800 Lyngby, Denmark.
ABSTRACT: Flocoumafen is a new anticoagulant rodenticide with an acute toxicity between that of bromadiolone and 
brodifacoum. It has performed well in field tests against house mice and susceptible as well as resistant brown rat populations. 
Danish lab tests reveal a considerable variation in susceptibility between rodent species and indicate that practical problems 
in the control of certain Scandinavian bromadiolone-resistant house mouse populations may arise shortly after introduction.
Proc. Vertebr. Pest Conf. (A.C. Crabb and R.E. Marsh, Eds.), 
Printed at Univ. of Calif., Davis. 13:53-58, 1988
INTRODUCTION
The increasing problems in the control of rodent popu-
lations resistant to the anticoagulant rodenticides also have 
certain positive aspects. Commercial interests in synthesiz-
ing, screening and introducing new products on the market of 
rodent control have been greatly stimulated. First, the more 
potent hydroxycoumarins difenacoum and bromadiolone 
became important alternatives to the older anticoagulants in 
the mid-seventies. Then the completely different, but still 
slow-acting compounds, the calciferols, were introduced, 
especially in countries with practical resistance problems. 
Almost at the same time the highly efficient anticoagulant 
brodifacoum appeared, and most recently another slow-
acting rodenticide, bromethalin, as well as two new antico-
agulants, difethialone and flocoumafen, have been devel-
oped. Flocoumafen (4-hydroxy-3-[l,2,3,4-tetrahydro-3-[4-
(4-trifluormethylbenzyloxy)phenyl-l-napthylcoumarin) 
was synthesized in 1984 by Shell International Chemical Co. 
Ltd., and it was marketed in several countries under the trade 
name of STORM, formulated as loose grain bait, small 
pellets, and wax blocks for rats and mice - all at concentra-
tions of 0.005% flocoumafen.
LABORATORY DATA ON TOXICITY AND EFFICACY 
The acute oral LD50 is for most species reported to be 
below 1 mg/kg, but it varies considerably from 0.12 mg/kg in 
Microtus arvalis to more than l0mg/kginAcomyscahirinus. 
a species remarkably tolerant to most anticoagulants (Table 
1). The acute toxicity of flocoumafen to the three major 
commensal rodent species is compared with that of difena-
coum, bromadiolone, and brodifacoum in Table 2.
Tests with warfarin-resistant strains of rats and mice 
indicate that flocoumafen will perform well in practice to 
most populations. The only species in which the resistance 
factor is significantly increased is the house mouse (Table 3).
TOXICITY TO NON-TARGET ANIMALS
Flocoumafen is generally less toxic to non-target species 
than to rats as can be seen from the following figures, where 
the dog is an important exception from the rule (Johnson et 
al. 1986): Pig 70 mg/kg; Hen < 100 mg/kg; Quail 100 - > 300 
mg/kg; Duck 24-94 mg/kg and Dog 0.075 - 0.25 mg/kg. As
far as the dog is concerned, brodifacoum has been reported to 
be similarly toxic (Dubock et al. 1980), whereas the acute 
LD50 of bromadiolone to dogs is above 10 mg/kg (Grand 
1976).
Of the three STORM formulations the biconvex wax 
block is the principal bait formulation selected for the 
commercialization of flocoumafen. It seems to be attractive 
to small children, but the addition of a substance tasting 
highly bitter to humans and not to rodents is an important 
improvement compared with all other rodenticide formula-
tions. Predators, including dogs, are, however, still at some 
risk of being poisoned by consuming these blocks, but they 
have been found unattractive to birds (Garforth et al. 1987). 
Like the other 'second generation' anticoagulants, flo-
coumafen has a long biological half-life. This first of all has 
the consequence that the vitamin Kj treatment of accidentally 
poisoned animals or humans must be considerably pro-
longed, e.g., for several weeks (Shell 1987b). Dead rodents 
collected during field trials have been found to contain 1 -3 
mg flocoumafen per kg, on average 25 times less than the bait 
itself.
FIELD TRIALS WITH RATS
In the UK 12 farmsteads with documented rat infesta-
tions in the warfarin-resistance area were treated with me-
dium oat meal containing 0.005% flocoumafen (Buckle 
1986). On half of the premises the traditional, unrestricted 
baiting method was applied using 100-g depots at a high 
number of baiting points and maintaining a surplus through-
out the treatment. On the other half a restricted treatment was 
carried out, starting with only 50 g of bait and replenishing 
only twice a week until bait take had ceased. Complete 
control was achieved in both types of treatment, but the 
amount of bait used was considerably larger in the traditional 
treatment, whereas the time used to complete control was one 
week shorter.
In another series of 12 similar UK field trials with 
flocoumafen wax blocks carried out by the Ministry of 
Agriculture, Fisheries and Food an average kill of 99.2% was 
achieved on half of the premises where unrestricted baiting 
was carried out compared with a 96% reduction in rat 
numbers, where the baiting was restricted to two instead of
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Table 1. The acute oral toxicity of technical flocoumafen to 
various rodent species and the New Zealand white rabbit. 
(Shell 1987a).
three blocks per baiting point and where the baiting period 
was reduced from 29 to 21 days (Johnson 1988). In South East 
Asia oil palm trees are reported to have been protected again st 
damage from Rattus tiomanicusby baiting with flocoumafen 
wax blocks, one per tree at 4-day intervals (Shell 1987a). 
Damage from Rattus argentiventer to tillers in ricefields in 
Thailand was reduced from 5.05 % to 0.65 % by using 0.005 
% flocoumafen rice bait (Shell 1987a).
Table 2. The acute LD50 of four 'new' anticoagulant roden-
ticides to susceptible strains of the three major commensal 
rodent species (mg/kg).
FIELD AND PEN TRIALS WITH HOUSE MICE
Ten field trials carried out by the Ministry of Agriculture, 
Fisheries and Food on mouse-infested farms in Sussex, UK, 
using 0.005 % flocoumafen baits based on oat meal, resulted 
in complete eradication in seven cases and a reduction in 
numbers on the other farms ranging from 87.1% to 95.5%. 
On eight farms the results were achieved in 3-4 weeks and in 
two cases the treatment period was prolonged to 5 and 6 
weeks, respectively. No resistance was detected in survivors 
trapped and tested in the laboratory (Rowe et al. 1985). 
Compared with previous field trials conducted in a similar 
way with difenacoum, bromadiolone and brodifacoum, 
flocoumafen turned out to be just as efficient, or even better, 
particularly as far as the length of the treatment period is 
concerned.
Four pen trials with family groups of house mice from a 
warfarin-resistant strain resulted in a complete kill when 
baiting with 0.005 % flocoumafen in pinhead oatmeal to-
gether with plain food. Only 5 mice out of 68 survived for 
more than seven days. The results are comparable with, or
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slightly better than those obtained with other anticoagulants 
in similar tests (Rowe et al. 1985). Four similar trials with 
flocoumafen wax blocks also resulted in a 100% mortality in 
the same strain of house mice (Johnson 1988), but the bait had 
to be presented for a longer period, e.g., 16 instead of 10 days.
LABORATORY TESTS CARRIED OUT WITH FLO-
COUMAFEN IN DENMARK
Very recently (January, 1988) flocoumafen has been 
registered for rat control by the Danish Ministry of the 
Environment and after efficacy testing approved by the 
Danish Pest Infestation Laboratory. For the present wax 
blocks have only passed the registration process, but the 
pellet formulation has also been approved and may soon 
appear on the market.
Apart from LD50 tests incorporated into Table 1, feeding 
tests with singly caged as well as groups of rodents have been 
carried out since 1984. In tests with singly caged rodents the 
bait was offered as the only food for a varying number of day s; 
in the group tests the rodents were offered a nonpoisonous 
alternative.
The effect on singly caged brown rats of baits containing 
from 5 ppm to 80 ppm flocoumafen and with feeding periods 
varying from 24 hours to 6 days is summarized in Table 4. In 
most cases survival was due to individual rats refusing to
feed. A complete kill of bromadiolone-resistant rats was 
achieved after a 6-day feeding period using a 40-ppm or 50-
ppm flocoumafen bait. The highest dose survived by a rat 
from the resistance area was 1.1 mg/kg.
House mice in Western Europe have recently been found 
to belong to two different species, Mus domesticus and M-
musculus. Whereas the former species is the only one found 
in the UK, both species are abundant in Denmark. No 
difference has previously been detected between the two 
species as far as susceptibility to warfarin is concerned, but 
in Table 5 on feeding tests with Danish house mice a tendency 
can be seen of a higher tolerance to flocoumafen in M. 
musculus than in M- domesticus. This may explain some of 
the differences between the figures given for house mice in 
Table 1 and those appearing from the Danish tests.
The highest dose survived by M- musculus in the Danish 
tests is 13.5 mg/kg, and that by M- domesticus 5.6 mg/kg. 
The higher mortality obtained with wax blocks as well as 
with a cereal bait formulated by Sorex, compared with a 
broken barley bait, may also indicate that mice are capable 
of selecting less toxic particles from certain bait types.
Results from tests on house mice from a warfarin and 
bromadiolone-resistant strain are summarized in Table 6. A 
complete kill could not be achieved in a 24-hour test, even if 
the concentration was raised to 320 ppm.  Survivors con-
Table 4. The effect of various concentrations and formulations of flocoumafen on singly caged brown rats (Rattus norvegicus')
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Table 5.The effect of various concentrations of flocoumafen on singly caged house mice (Mus musculus (m) and M-
domesticus (d)) from warfarin-resistant strains. Varying test periods. No choice. Sorex formulation: cut wheat.
Table 6. The effect of various concentrations of flocoumafen on singly caged house mice (Mus musculus) from a warfarin-
resistant strain. Feeding period 24 hours. No choice. Sorex formulation: cut wheat.
sumed up to 51.69 mg/kg. Survivors have also been seen in 
this strain in feeding tests with brodifacoum (0.005%) for 24 
hours and 48 hours (Lund 1981).
Table 7 represents results obtained with some other 
rodent species. A complete kill was not obtained with Rattus 
rattus in a 24-hour test, even at concentration s up to 160 ppm. 
This was partly due to bait refusal as the maximum amount 
of a.i. consumed by a survivor was 2.3 mg/kg.
As can be seen in Table 1 on the LD50 values for various 
rodent species, the European Apodemus species seem to be 
relatively tolerant to flocoumafen. This is confirmed in Table 
7 showing that a few A. flavicollis survived doses up to 16.39 
mg/kg.
A certain tolerance and individual variation in suscepti-
bility is also seen in the short-tailed field vole (Microtus
agrestis) where five individuals survived doses ranging from 
10.2 to 21.2 mg/kg. The multimammate rat (Mastomys 
(Praomys) natalensis*) was as susceptible to flocoumafen as to 
bromadiolone (Lund et al. 1986), a single individual surviv-
ing, however, a 48-hour test after having consumed 7.3 mg/ 
kg. The acceptance of various STORM products studied in 
choice tests with a non-poisonous cereal as the alternative, 
was satisfactory, especially as far as the wax blocks are 
concerned (Table 8). This is remarkable, as this product 
contains not only an insecticide and a fungicide, but also the 
previously mentioned bitter substance intended to increase 
safety by being a taste deterrent to man but not to rodents. A 
tendency was seen in the palatability tests of the rodents 
transporting the blocks from the baiting site to a shelter, 
where they were consumed, not stored. If the blocks were
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Table 7. The effect of various concentrations and formulations of flocoumafen on singly caged rodents. Varying test periods. 
No choice.   Sorex formulation: cut wheat.
crushed, transporting ceased and palatability was improved. 
Experience from field trials on wax blocks also indicates that 
transporting is of minor practical importance, if the blocks are 
placed in rat holes or in bait boxes (Garforth et al. 1987).
TESTS WITH PIGEONS
To investigate the risk of flocoumafen to a non-target 
species often feeding at rat infested sites, an 0.005% flo-
coumafen cereal bait was offered to singly caged pigeons as 
the only food for four days. As can be seen from Table 9 one 
pigeon succumbed after an intake of 5.87 mg/kg. Two others 
were bleeding shortly after having consumed only 0.74 mg/ 
kg and 4.7 mg/kg, respectively. Seven pigeons did not show
any symptoms of anticoagulant poisoning, presumably be-
cause they refused to consume more than tiny amounts of the 
bait. This preliminary study seems to indicate that flo-
coumafen is somewhat more toxic to this bird species than to 
hens.
CONCLUSIONS
Flocoumafen is a promising new anticoagulant rodenti-
cide with an acute potency between that of bromadiolone and 
brodifacoum, but with considerable variation between spe-
cies. Practical control problems with certain resistant house 
mouse populations in Scandinavia are likely to occur in the 
not-too- distant future.
Table 8. The effect of 0.005% flocoumafen baits on groups of rodents with non-poisonous choice. Test period: 4 days.
57
Table 9. The effect of 0.005% flocoumafen on cut wheat on 
singly caged pigeons (Columba livia) offered the bait as the 
only food for four days.
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